Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
Inidascamine continues to exhibit a favorable safety and tolerability profile
Full data set, including secondary endpoints and subgroup analyses will be forthcoming
SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.
While the study did not achieve statistical significance on its primary endpoint of improvement on the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB) neurocognitive composite score at Week 6, inidascamine demonstrated a modest but consistent numerical improvement across the overall MCCB neurocognitive composite and multiple individual subdomains, including Symbol Coding, Speed of Processing and Verbal Learning (immediate recall). Directionally positive effects were also observed on the Virtual Reality Functional Capacity Assessment Tool (VRFCAT), a measure of real-world functional cognitive capacity.
Inidascamine was well-tolerated, with a favorable safety profile consistent with previous studies. Importantly, no evidence of sedation, weight gain, or extrapyramidal symptoms was observed, which are side effects commonly associated with treatments used in people living with schizophrenia.
Matt Pando, PhD, Chief Executive Officer and Co-Founder of Recognify Life Sciences, commented: 'Although we are disappointed that the study did not reach statistical significance on the primary efficacy endpoint, we are encouraged by the consistency of improvement signals across multiple cognitive and functional measures as well as replication on specific subsets of the cognitive measures; namely, symbol coding and verbal memory. These findings reinforce our commitment to addressing the significant unmet needs of cognitive impairment associated with numerous mental health and neurodegenerative conditions. Inidascamine continues to exhibit a strong safety profile, and we look forward to analyzing the full data set to better understand the outcome and inform potential next steps for the program.'
The randomized, placebo-controlled, double-blind, Phase 2b clinical study enrolled 242 patients across the United States and Europe (NCT05686239). The trial evaluated the efficacy, safety, and tolerability of two doses of inidascamine versus placebo over a six-week treatment period. A comprehensive analysis of remaining secondary and exploratory endpoints, including subgroup analyses, is ongoing to determine whether there are identifiable responder populations or mechanistic insights that may guide future development.
Keith Nuechterlein, PhD, Distinguished Professor in the UCLA Department of Psychiatry and Biobehavioral Sciences and co-chair of the MATRICS Neurocognition Committee, commented upon seeing these results: 'Developing treatments for cognitive impairment in schizophrenia is a complex challenge that requires persistence and innovation. I am encouraged by the inidascamine topline results showing consistent directional tendencies for improvement and look forward to seeing the full set of results.'
Recognify plans to present additional results from the study at upcoming scientific meetings and will continue to evaluate strategic options for inidascamine based on the totality of data.
Srinivas Rao, MD, PhD, Chief Executive Officer and Co-Founder of atai Life Sciences, added: 'CIAS remains a challenging therapeutic area with a significant unmet need. While we believe these results support the continued development of inidascamine by Recognify for CIAS as well as its potential application in other indications, as previously communicated, we intend to allocate atai's resources on our wholly owned pipeline of transformative psychedelic product candidates focused on affective disorders."
About Inidascamine Inidascamine, formerly RL-007, is an orally available compound, with unique mechanisms of action for the treatment of cognitive impairment, that modulates cholinergic, glutamatergic and GABA-B receptors, thereby putatively altering the excitatory/inhibitory balance in the brain to produce pro-cognitive effects. It has previously been evaluated in ten clinical studies, including one in the CIAS indication, with over 600 unique participants dosed to date. Clinical studies of inidascamine suggest improvement in cognitive performance, particularly for verbal learning and memory and processing speed.
About Schizophrenia and CIASSchizophrenia is a mental health disorder primarily characterized by hallucinations, delusions, and disordered thinking. This condition effects over 21 million people globally and approximately 2.4 million people in the United States, with around 300,000 new cases being diagnosed each year in the US. Cognitive deficits -present in approximately 80% of patients, is a core feature of the illness and contributes significantly to long-term disability and impairments in daily functioning. There are presently no effective pharmaceutical treatments approved for CIAS, representing a high unmet clinical need.
About Recognify Life Sciences, Inc.Recognify Life Sciences is a clinical-stage biotech company on a mission to provide pro-cognitive treatments solutions to mental health and neurodegenerative disorders. The company is a strategic investment of atai Life Sciences. For more information about Recognify, please visit www.recognify.life.
About atai Life Sciencesatai is a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes. atai's pipeline of psychedelic-based therapies includes BPL-003 (mebufotenin benzoate) for treatment-resistant depression (TRD), which is being advanced through a planned strategic combination with Beckley Psytech Limited; VLS-01 (buccal film DMT) also for TRD; and EMP-01 (oral R-MDMA) for social anxiety disorder. All three programs are in Phase 2 clinical development. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD. These programs aim to address the complex nature of mental health providing commercially scalable interventional psychiatry therapies that can integrate seamlessly into healthcare systems. For the latest updates and to learn more about atai's mission, visit www.atai.com or follow the Company on LinkedIn and on X.
Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). The words 'believe,' 'may,' 'will,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'initiate,' 'could,' 'would,' 'project,' 'plan,' 'potentially,' 'preliminary,' 'likely,' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these words. All statements in this press release other than statements of historical fact are forward-looking statements, including, express or implied statements relating to, among other things: statements regarding Recognify Life Science's inidascamine (formerly RL-007) studies, data, or related strategic plans and objectives of management for future operations, capital expenditures and capital allocation. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond our control and which could cause actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements.
Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation, the important factors described in the section titled 'Risk Factors' in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ('SEC'), as such factors may be updated from time to time in atai's other filings with the SEC. atai disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by applicable law.
Contact InformationInvestor Contact:IR@atai.com
atai Media Contact:PR@atai.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
11 Signs Your Child Is Too Competitive and What To Do About It
Reviewed by Charissa Chamorro, PhD We've all heard the saying: 'A little competition never hurt anyone.' In fact, you likely see a touch of competitiveness in just about everyone, including yourself. But how does competitiveness apply to kids? Experts say while competition is a natural part of human makeup that drives people, including kids, to do their best, it also can morph into something unhealthy—especially if your child cannot tolerate losing and struggles every time they are faced with challenges. 'Our brains are wired to compete,' explains Christina Lee, MD, a psychiatrist at Kaiser Permanente in Maryland. 'Competition can be a very positive drive to motivate you to do better and to learn to improve your performance. But the problem is in children who have underdeveloped brains and the inability to necessarily temper [emotions], impulsive competitiveness can spiral into the negative aspects like self-criticism or perfectionism.' Dr. Less says unhealthy competitiveness may start with getting upset over losing a board game. Then, as your child gets a little bit older, they may start obsessing over their grades, insisting on being first in line, and even refusing to try hard things because they are afraid to fail, she says. 'When someone's self-worth starts becoming contingent on winning, achievements, or out-performing other people, that's where it's really time to take a closer look,' says Dr. Lee. 'An unhealthy competitive mindset can ultimately crowd out enjoyment, curiosity, and the healthy risk-taking that is needed to explore—and all the positive benefits of competitiveness go out the window when it starts going down that path.' Understanding Competitive Behavior in Children Competitiveness in children is often overt, says Cynthia Vejar, PhD, LPC, LSC/PPS, NCC, associate professor and director of the CMHC/SC/TR Cert. Programs at Lebanon Valley College. Most kids haven't yet developed the nuanced mannerisms that allow them to conceal their competitiveness that adults typically acquire. 'While adults may be just as, if not more, competitive, they often hide it behind subtle behaviors, passive comments, or strategic social graces,' says Dr. Vejar. 'In contrast, children tend to express their competitiveness in more obvious ways, such as bragging, name-calling, or becoming hyper-emotional when they lose.' Their emotional regulation is still developing, so their reactions tend to be worn on 'their sleeves,' she says. This isn't necessarily negative, as it offers clear insight into their thoughts and emotions, but it also means you need to teach them how to handle both winning and losing, as well as developing grace, empathy, and perspective, she says. Here are some ways you might witness competitiveness in school, sports, and social interactions. School: According to Dr. Vejar, kids may strive for the highest grades, as well as seek approval from teachers. 'On the positive side, this can motivate hard work, but it can also lead to stress or perfectionism, as well as cheating behavior.' Sports: In sports, competition can be physical and aggressive, says Dr. Vejar. Kids may push themselves and their teammates, which can lead to burnout, resentment, and ultimately take the fun out of hobbies and activities, she says. Conversely, kids can move past their comfort levels and develop exceptional talent, she says. Social interactions: In peer groups, Dr. Vejar says competition shows up as trying to be the most popular, have the trendiest clothes and technology, and get the most attention. This can manifest in appearance, talent, and social status, she says. The Impact of Excessive Competitiveness While a little bit of competition can be healthy for kids, Dr. Lee says too much can create chronic stress that can lead to burnout, de-prioritizing collaboration, and even lying about their accomplishments. It also can steal their joy for activities they once loved—especially in sports and other similar activities. In fact, the American Academy Pediatrics reports that 70% of kids quit organized sports by age 13 because of performance pressure and the amount of unhealthy competition they experience, she says. 'Excessive pressure [and unhealthy competitiveness] raises the risk for depression, anxiety, panic attacks, and sleep issues,' says Dr. Lee. 'It can sometimes even lead to substance misuse in adolescence.' Unhealthy competitiveness also can cause kids to disconnect from their core values and sense of self beyond the activity, adds Carla Allan, PhD, division chief of psychology for Phoenix Children's. 'Some may withdraw, freeze, or quit, while others may act out with intense, persistent anger towards peers, parents, coaches, or themselves—disrupting their overall quality of life,' says Dr. Allan. 'In most cases, without intervention, children will gradually show more frequent and intense signs of dysregulated behavior. For example, a child who exhibits physical aggression often displays verbal aggression first.' As they get older they may even resort to cheating in order to win. And, if they are in sports, excessive competitiveness and a desire to be the best, can even lead to the use of performance enhancing drugs. Signs Your Child Is Too Competitive When kids are overly competitive, Dr. Lee says they may be reluctant to try new things or to undertake challenges, especially if they believe they might not succeed. They may fear failure and become withdrawn as a result. You also may see a lot of negative self-talk, self-criticism, extreme emotions after a loss, and an inability to recover from losses and failures, she says. Here are some other signs of excessive competitiveness that our experts say you may witness: Constant comparisons with peers Fear of failure or not being good enough Lack of collaboration or cooperation Acting out after losing a competition or failing a test Avoidance of competitions or sporting events Boastful behavior or bragging and putting down others Unable to be a team-player or share credit for winning Perfectionism and unrealistic expectations of self and others Pressure to constantly perform or present a perfect image Feelings of inadequacy or exclusion Alienating friends or being rejected by others The Role of Social Media While social media, like TikTok and Instagram, can provide a platform for connection, it can also encourage competitive behaviors, especially in teens, says Judy Krause, EdD, executive director of Early Childhood Programs at Pacific Oaks College. 'These platforms often foster a sense of competition,' says Dr. Krause. 'While online, teens compare themselves with others, wanting to be popular. Peer pressure leads them to participate in virtual trends, which can be harmful.' With social media, there's a built-in culture that emphasizes recognition, adds Dr. Vejar such as how many 'likes' one gets, how many friends they have, and the types of comments they get on a post. 'This can create pressure to constantly perform or present a perfect image, while also triggering feelings of inadequacy or exclusion such as FOMO [fear of missing out].'You can reduce these risks by setting time limits for screen time, encouraging real-world or offline friendships, and modeling healthy technology habits, says Dr. Vejar. 'The problem with social media is that it turns normal, every day life into a competition or a scoreboard,' adds Dr. Lee. 'It ends up perpetuating this idea that everyone's highlight reel is better…and there's a huge divide that makes kids feel terrible and fuels their anxiety. So, have open conversations with your kids about how social media is not real and is a very filtered version [of someone's life].' Strategies for Parents to Encourage Healthy Competition When it comes to competition, work with your kids to provide balance, says Dr. Krause. 'Rather than focusing on winning, concentrate on effort and accepting loss. Shift the focus to teamwork. Engage in conversations about feelings. Children are looking to [you] for support; be the model for finding the fun in the competition.' If you are constantly focusing on accomplishments and winning, Dr. Lee says that's going to make your child feel bad when they don't obtain that. Instead, shift your focus to progress like comparing how a child did in the past and how they do now. Dr. Lee says you can encourage healthy competition, instead. Here's how: Praise effort over outcome: 'Research shows that kids who are praised for their hard work and their effort actually go on to develop much stronger resilience, can recover better from setbacks, and learn to cope with disappointment or frustration, when they feel supported and loved regardless of whether they win or lose,' she says. Rotate sports and activities: Strive for a balance of competitive and non-competitive activities and avoid specializing in a sport too early, says Dr. Lee. 'The American Academy of Pediatrics against pigeon-holing them into being the sports player, gymnast, or cheerleader. Try different sports throughout the year and then take several months off from any single sport. You want your child to kind of figure out what they enjoy and what they would excel at doing. You also want to encourage teamwork and cooperation over winning.' Model healthy and positive attitudes toward competition: Achievements should be celebrated, says Dr. Lee. But they're also not representative of who your child is. 'Anybody can have a good or bad day, so it's important to teach children how to keep a healthy perspective. It's also important to encourage kids to prioritize rest and recovery. It's not an optional thing; it's essential and helps reduce burnout," she explains. Talk about what success means: So many young people think success is all about winning, says Dr. Lee. 'But if you teach your child that success might mean being a good person, being a good teammate, being supportive, trying something new, or doing something even when you know that you're going to fail you have redefined the term success and redefined the term winning. That can help build long-term confidence. Remind them that having fun is the goal: The reason why children start doing competitive things like sports is because they are fun, says Dr. Lee. 'So, remind them that having fun should be the goal, not winning. Also encourage them to try something new and not just focus on the things they are good at.' Read the original article on Parents Solve the daily Crossword
Yahoo
6 minutes ago
- Yahoo
Celcuity Stock Triples on Positive Breast Cancer Treatment Study
Shares of Celcuity (CELC) tripled to an all-time high after the biotech firm announced positive results in a late-stage study of its experimental treatment for adults with two kinds of breast cancer. The company reported primary endpoints were reached in the Phase 3 trial of gedatolisib, combined with two other drugs, palbociclib and fulvestrant, which it calls the "gedatolisib triple." It said the three together reduced the risk of disease progression or death by 76% compared to fulvestrant alone. A "gedatolisib double" combination of gedatolisib and fulvestrant cut risk of disease progression or death by 67% versus fulvestrant alone, also exceeding endpoints. The patients tested suffered from "hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA wild-type, locally advanced or metastatic breast cancer, following progression on, or after, treatment with a CDK4/6 inhibitor and an aromatase inhibitor." Dr. Sara Hurvitz, co-principal investigator of the trial, said to her knowledge, "we have not seen Phase 3 results in patients with HR-positive, HER2-negative advanced breast cancer before where there was a quadrupling of the likelihood of survival without disease progression relative to the study control." Dr. Igor Gorbatchevsky, Chief Medical Officer at Celcuity, added that the results showed gedatolisib could be a "transformative new medicine" for the treatment of those breast cancers. The company plans to submit a New Drug Application to the Food and Drug Administration (FDA) for gedatolisib in the fourth quarter. Celcuity shares, which entered the day up 5% this year, soared 210% less than an hour after the opening bell Monday. Read the original article on Investopedia Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Deion Sanders reveals he made a will in May, thinking he might not be here
Deion Sanders and his medical team plan to discuss his health at a press conference today. Ahead of that press conference, it's been revealed that Sanders' health issues are serious enough that he wrote his will in May, thinking he might not live much longer. In a video released late last night but shot by his son, Deion Sanders Jr., on May 9, Coach Prime talks about how concerned he was about his health. "Mentally, emotionally, last night was tough, yesterday was tough, because I had to make a will. That's not easy at all, to think that you may not be here," Sanders said. A month after making that video, Sanders said everything is OK. And he looked and sounded healthy when he attended the Big 12 media days this month in his capacity as Colorado's head coach. And Sanders Jr. also posted on social media that his father had "a hard fought battle, but it was a battle that was fought and won.' Whatever the unspecified health issue was, it was serious enough that it was a major concern for Sanders as recently as a few months ago. More clarity should come today.
